1. Home
  2. LTRN vs CFND Comparison

LTRN vs CFND Comparison

Compare LTRN & CFND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRN
  • CFND
  • Stock Information
  • Founded
  • LTRN 2013
  • CFND N/A
  • Country
  • LTRN United States
  • CFND
  • Employees
  • LTRN N/A
  • CFND N/A
  • Industry
  • LTRN Biotechnology: Pharmaceutical Preparations
  • CFND
  • Sector
  • LTRN Health Care
  • CFND
  • Exchange
  • LTRN Nasdaq
  • CFND Nasdaq
  • Market Cap
  • LTRN 49.9M
  • CFND 55.7M
  • IPO Year
  • LTRN 2020
  • CFND 2025
  • Fundamental
  • Price
  • LTRN $4.00
  • CFND $7.78
  • Analyst Decision
  • LTRN Strong Buy
  • CFND
  • Analyst Count
  • LTRN 1
  • CFND 0
  • Target Price
  • LTRN $25.00
  • CFND N/A
  • AVG Volume (30 Days)
  • LTRN 177.8K
  • CFND N/A
  • Earning Date
  • LTRN 11-06-2025
  • CFND N/A
  • Dividend Yield
  • LTRN N/A
  • CFND N/A
  • EPS Growth
  • LTRN N/A
  • CFND N/A
  • EPS
  • LTRN N/A
  • CFND N/A
  • Revenue
  • LTRN N/A
  • CFND N/A
  • Revenue This Year
  • LTRN N/A
  • CFND N/A
  • Revenue Next Year
  • LTRN N/A
  • CFND N/A
  • P/E Ratio
  • LTRN N/A
  • CFND N/A
  • Revenue Growth
  • LTRN N/A
  • CFND N/A
  • 52 Week Low
  • LTRN $2.55
  • CFND N/A
  • 52 Week High
  • LTRN $6.12
  • CFND N/A
  • Technical
  • Relative Strength Index (RSI)
  • LTRN 43.96
  • CFND N/A
  • Support Level
  • LTRN $3.89
  • CFND N/A
  • Resistance Level
  • LTRN $4.58
  • CFND N/A
  • Average True Range (ATR)
  • LTRN 0.28
  • CFND 0.00
  • MACD
  • LTRN -0.04
  • CFND 0.00
  • Stochastic Oscillator
  • LTRN 18.44
  • CFND 0.00

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

About CFND C1 Fund Inc. Common Stock

C1 Fund Inc is a non-diversified, closed-end management investment company designed to give investors access to the private digital asset ecosystem. Its investment objective is to maximize its portfolio's total return. The fund targets a handpicked portfolio of the late-stage private companies driving the future of digital asset services and technology. It offers early access to the next generation of category-defining companies and aims to bridge the gap between public and private markets and give investors access to the private companies with the safeguards of a NYSE listed fund that is regulated and liquid.

Share on Social Networks: